Characterization of multidrug resistance-associated protein mRNAs expression profiles in Caco-2 and HT-1080 cell

K Ikeda1, M Myotoku, Y Hirotani

  • 1Laboratory of Clinical Pharmaceutics, Faculty of Pharmacy, Osaka Ohtani University, Tondabayashi, Osaka, Japan. ikedak@osaka-ohtani.ac.jp

Die Pharmazie
|January 31, 2009
PubMed

Insights

Multidrug resistance-associated proteins (MRPs) influence methotrexate (MTX) resistance. This study compared MRP mRNA expression in MTX-resistant Caco-2 and MTX-sensitive HT-1080 cells, revealing distinct profiles linked to resistance.

Area of Science:

  • Pharmacology and Molecular Biology
  • Cancer Cell Biology
  • Drug Resistance Mechanisms

Background:

  • Multidrug resistance-associated proteins (MRPs) mediate drug efflux, contributing to resistance against chemotherapeutic agents like methotrexate (MTX).
  • The Caco-2 cell line exhibits high MRP expression and is presumed resistant to MTX, while the HT-1080 cell line is reportedly sensitive.
  • Understanding differential MRP expression is crucial for elucidating MTX resistance mechanisms in cancer cells.

Purpose of the Study:

  • To compare the growth-inhibitory effects of MTX on Caco-2 and HT-1080 cell lines.
  • To characterize the mRNA expression profiles of MRPs (1-8) in both cell lines before and after MTX exposure.
  • To investigate the association between MRP expression patterns and MTX sensitivity.

Main Methods:

  • Comparative analysis of MTX growth-inhibitory activity in Caco-2 and HT-1080 cells.
  • Multiplex reverse-transcription-polymerase chain reaction (RT-PCR) to quantify MRP (1-8) mRNA expression.
  • Examination of MRP mRNA expression profiles pre- and post-MTX treatment.

Main Results:

  • HT-1080 cells displayed lower mRNA expression of MRP2, MRP3, MRP6, and MRP8 compared to Caco-2 cells.
  • MRP5 mRNA expression was specifically induced in Caco-2 cells following MTX treatment.
  • Significant differences in MRP mRNA expression profiles were observed between the two cell lines.

Conclusions:

  • Differential MRP mRNA expression profiles correlate with varying MTX sensitivity in Caco-2 and HT-1080 cells.
  • Characterization of MRP expression is potentially linked to MTX resistance mechanisms.
  • The multiplex RT-PCR method is a valuable tool for time-dependent investigations of MRP mRNA expression.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...